TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that are designed to optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit trialscope.com.
185 Hudson St #2900
Jersey City, NJ 07311
Contact: Naor Chazan
Transparency remains a buzzword in today’s society: transparency in government (such as Sunshine Laws), transparency in politics (revealing sources of donations), transparency in finance (SEC regulations), transparency in relationships. The pharmaceutical industry has recently been under pressure to increase transparency in drug pricing. All companies, regardless of the industry, should revisit their commitments to transparency. Here’s why.
Like any department within a pharmaceutical organization, clinical trial disclosure teams contribute to the bottom line and must be accountable. Here are five key performance indicators (KPIs) to monitor on a regular basis.
See how sponsors are employing technology to replace outdated, paper-based patient communications about trial results. This innovative approach enables clinical trial sponsors to meet their ethical obligations to trial participants while simultaneously increasing patient engagement.
TrialScope has worked with EMD Serono, the North American branch of the healthcare business of Merck KGaA, and CISCRP to launch a new clinical trials website. The site is designed to inform the public and healthcare professionals about the clinical trial journey and EMD Serono clinical trials.
The Good Pharma Scorecard, as its acronym suggests, is the industry GPS for clinical trial transparency. See what this year's top-ranked sponsors all have in common.
Want to reduce QC comments? Hear tips from Dr. Deborah Zarin, former director of ClinicalTrials.gov, now with the MRCT Center. Dr. Zarin was keynote speaker at the recent EXTRA: TrialScope Transparency Experience.
Matt DeFranco, TrialScope Director of Solution Engineering, shares success stories on how to make the most of clinical trial data. It’s all about ETL – extract, transfer and load. Listen to his presentation at the recent EXTRA: TrialScope Transparency Experience.
Two senior transparency and disclosure experts discussed their successful clinical trial website launches at the recent EXTRA: TrialScope Transparency Experience. They talked about challenges, getting management buy-in, and how to keep visitors coming back.
At the recent EXTRA: TrialScope Transparency Experience, representatives from three patient advocacy groups shared thoughts on how sponsors can partner to promote clinical trials. Hear insights from Susan Thornton, CEO of the Cutaneous Lymphoma Foundation; Stephanie Cogan, Vice President of Corporate Relations, National Kidney Foundation; and Ali Sue Patterson, Senior Specialist, Clinical Research Community Engagement, Cystic Fibrosis Foundation.
Who can reflect better on this topic than Dr. Deborah Zarin, former director of ClinicalTrials.gov? Dr. Zarin, now with the MRCT Center, shared her experiences and advice at the recent EXTRA: TrialScope Transparency Experience.
Today, trial transparency and patient engagement go hand in hand. But don’t let the prospect of patient engagement scare you – join TrialScope and CISCRP for this informative webinar. You’ll discover how to obtain patient input and use it to guide your clinical trial processes and communications. And you’ll see what patients expect in terms of clinical trial engagement online – and how to deliver an improved digital experience to them.
TrialScope, the global leader in transparency and disclosure compliance solutions, has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will join the TrialScope team as Vice President of Patient Engagement.
See how website optimization tactics, such as user behavioral analysis, user feedback gathering and A/B tests, can improve the ROI on your clinical trial website. Plus, learn how tools such as heatmaps and scrollmaps track success.
If you think CRO stands for “contract research organization,” think again. In the digital marketing world, CRO means “conversion rate optimization.” This webinar provides an overview of key digital marketing concepts and how they can be applied to boost online clinical trial recruitment and retention.
TrialScope has released a new version of its TrialScope Disclose™ platform, featuring a revamped user interface (UI). The new functionality is specifically designed to expedite sponsors’ review and approval process for registering and updating clinical trials with regulatory agencies.
To many patients and caregivers, searching for clinical trials is a painstaking process. On top of that, medicalese is like a foreign language to them. Why make the process even more complicated by failing to translate your clinical trial information?
In this short video, learn the differences between on-page and off-page search engine optimization (SEO) for your clinical trial website.
Personalization is the process of creating a more customized experience for website visitors. One way to do this is to create clinical trial microsites. More tailored content enables you to engage with your visitors, who then will spend more time on your website.
If your clinical trial website is in English only, you’re missing out on about 95 percent of the world’s population. By providing translations in various languages, you provide your website visitors with an immersive experience in their native language.
Educating and engaging patients and caregivers via a clinical trial website helps boost study recruitment and retention. Learn how personalization, SEO, targeted ads, site optimization techniques and interactive tools can attract more qualified visitors.